Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients?
| dc.contributor.author | Ayerbe, L | |
| dc.contributor.author | Risco-Risco, C | |
| dc.contributor.author | Núñez-Gil, I | |
| dc.contributor.author | Perez-Piñar, M | |
| dc.contributor.author | Ayis, S | |
| dc.date.accessioned | 2021-02-08T12:51:28Z | |
| dc.date.available | 2021-02-08T12:51:28Z | |
| dc.date.issued | 2021-01 | |
| dc.identifier.issn | 2665-9913 | |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/70165 | |
| dc.description.abstract | CORRESPONDENCE | |
| dc.language | en | |
| dc.publisher | Elsevier BV | en_US |
| dc.relation.ispartof | The Lancet Rheumatology | |
| dc.title | Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients? | en_US |
| dc.type | Article | en_US |
| dc.identifier.doi | 10.1016/s2665-9913(21)00031-x | |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.publisher-url | https://doi.org/10.1016/S2665-9913(21)00031-X | |
| rioxxterms.funder | Default funder | en_US |
| rioxxterms.identifier.project | Default project | en_US |
